Grespo AB
556710-0275ActiveYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2006
- Founded
Description
Grespo is a young biomedical company based in Sweden specializing in the prevention and treatment of Central Nervous System (CNS) diseases. The core of their research focuses on leveraging the therapeutic effects of the substance 2-oxoglutarate (2-OX) within the body. Their primary clinical targets...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556710027501
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrScandiBio Therapeutics AB
0 employeesAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
LobSor Pharmaceuticals Aktiebolag
1–4 employeesDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Umecrine Cognition AB
1–4 employeesDeveloping novel drugs for neurological disorders caused by neuroinflammation.
AlzeCure Pharma AB
10–19 employeesSwedish pharma developing CNS drugs for Alzheimer's and pain.
Polku Therapeutics Oy
Developing novel therapies for debilitating neurodegenerative diseases.
Browse More
Grespo AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo